ASHPOfficial

Educators have noticed a growing trend of learners not exhibiting behaviors that will help them in the professional workforce, while learners might now understand the expectations educators will have of them. This podcast will shed the led the light on how professionalism is defined by different groups and how we can bridge the chasm that seems to exist. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast, Dr. Suzanne Harris and Dr. Charles Caley discuss the AJHP Practice Research Report, “Psychiatric learning experiences in PGY1 pharmacy residency training: A 5-year analysis,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast will provide an overview of how data analytics-related careers for pharmacy professionals will evolve as organizational needs and technology change. Panelists on this podcast currently work in data analytics-related roles and will discuss automation, predictive analytics, real-world evidence and artificial intelligence. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features Mariah Hollabaugh, director of pharmacy at Citizens Memorial Hospital, Hayle Gillespie, medication access specialist at Citizens Memorial Hospital, and Jodie Gregg, an advocate and patient. Gain insights into the diverse opportunities within the pharmacy profession and learn how pharmacists are making a difference every day. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This episode discusses the Food and Drug Administration and National Institutes of Health Biomarker Working Group updates to the original 2018 BEST Resource in 2021, including the understanding and classification of biomarkers like BRCA1 and BRCA 2. This presentation highlights how these changes affect cancer risk diagnostics and provides a resource for evidence-based application of specific genetic testing in the pharmacist’s clinical practice. CE for this episode expires two years after its original publication date. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join us as we explore providing data for specialty medication access. Hear from experienced individuals who detail their daily challenges, as well as considerations provided that may be helpful in your data for access journey. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This episode provides an overview of notable changes to state laws that have occurred thus far in 2025 and insight into key issues currently being considered in state legislatures, including efforts to broaden pharmacist scope of practice, achieve pharmacist provider status and regulate pharmacy benefit managers. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This episode dives into the Medicare Prescription Payment Plan (M3P), launched in 2025, and its impact on specialty pharmacies across the U.S. The episode discusses how this policy is changing patient access, pharmacy reimbursement, and operational strategies, while also highlighting the challenges and opportunities specialty pharmacies face in adapting to these shifts. Whether you're a healthcare professional, pharmacist, or policy expert, this episode unpacks everything you need to know about M3P and its role in shaping the future of specialty pharmacy. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this Pharmacy Leadership episode, David Chen sits down with the Section of Pharmacy Practice Leaders’ 2024 Awardee Della Bahmandar to discuss what membership within the Section and ASHP means to her and how it has helped her develop as a pharmacy practice leader. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This episode discusses the use of Platelet Factor 4, which has several roles for applicability, limitations, and emerging areas for use. CE for this episode expires two years after its original publication date. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This episode discusses a portion of the results of the work from home survey conducted in 2024 by members of the Section of Specialty Pharmacy Practitioners Advisory Group on Operational and Workforce Development. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

During this podcast, members of the New Practitioners Forum speak with pharmacy administrators and practitioners to explore the evolving landscape of hybrid pharmacy practice. Guests share insights into both inpatient and outpatient roles and discuss the benefits, opportunities, and challenges of hybrid work models.

This episode discusses the benefits of ASHP membership from the perspective of a student, seasoned practitioners, and professors. Speakers hope to inspire others to continue their involvement throughout their pharmacy career as a way to gain skills and further their careers and contribute to the advancement of the profession. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

The National Pharmacist Workforce Study is a systematic, nationwide survey of licensed pharmacists in the United States and provides data and trends over time and on contemporary issues. This most recent study includes information on job satisfaction, advancement opportunities, and workplace culture. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

During this podcast we will explore strategies and provide real-world examples to help preceptors increase engagement from students during their specialty pharmacy learning experiences. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features Kathy Parrinello, CEO and President of University of Rochester Medical Center Strong Memorial Hospital and Highland Hospital as she shares what drew her to a career in nursing, and her perspectives on the critical contributions of pharmacists within the health system setting. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This episode highlights changes made to the resource and revised categories of biomarkers and provides a resource for evidence-based application of biomarkers in clinical pharmacy practice. CE for this episode expires on June 21, 2027. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In 2024, ASHP conducted the fourth nationwide survey on specialty pharmacy. In this episode, members of the author team and advisory panel join us to share key takeaways and lessons learned from this most recent survey. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast explores the critical elements of physical wellness, offering tips for maintaining a healthy body through exercise, nutrition, and self-care. The episode also discusses building resilience and strategies for bouncing back from failure, highlighting the importance of mental fortitude and perseverance in both personal and professional growth. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast will provide members with an update on federal and state action on the 340B program. We’ll talk through 340B policy shifts at the federal level and what’s happening in the states. We’ll also discuss what we’re watching as 340B cases make their way through the courts. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast, Dr. Wendy St. Peter and Dr. Katie Cardone discuss the AJHP theme issue on the management of chronic kidney disease with host and AJHP Editor in Chief Dr. Daniel Cobaugh. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast will provide information about how preceptors can maximize remote learning opportunities. The speakers share practical advice on how to engage and motivate learners along with addressing challenges that occur with remote learning. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Pharmacists are pivotal in disease prevention and health promotion by advocating and administering immunizations. Despite increased access of vaccines which can prevent diseases, complications, and death, many adults in the US are not up to date on their immunizations. The Centers for Disease Control and Prevention and the Advisory Committee on Immunization Practices provide annual guidance on vaccine recommendations. This podcast will cover 2025 vaccine updates for pneumococcal, respiratory syncytial virus (RSV), Hepatitis B, and Monkeypox virus (Mpox) with ASHP ambulatory care pharmacists highlighting personal perspectives and tips from their varied practice sites. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, the team from Department of Veterans Affairs discusses their award winning submission to the ASHP Best Practices. They will share how their utilized a Clinical Pharmacist Practitioner model to improve access to medication for opioid use disorder and provided care to patients where they prefer to be treated. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, three clinical specialists discuss success stories, best practices, and strategies for motivating learners. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast, Mr. Jean-Philippe Adam, Dr. Mélodie Richard-Laferrière, and Dr. Félix Trudel-Bourgault discuss the AJHP Practice Research Report, “Teleworking by hospital pharmacists: Another step to achieve decarbonization of the healthcare system,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

A new ad hoc committee created as a collaboration between the Sections of Specialty Pharmacy Practitioners, Section of Pharmacy Practice Leaders, Section of Ambulatory Care Practitioners and Section of Inpatient Care Practitioners, the Infusion Services Strategy Committee began its work in August of 2024. Committee Chair, Samantha Bochenek, and Vice Chair, Noah Franz, join us on this podcast onsite at the ASHP Midyear Clinical Meeting to share some of their experiences within health system infusion services and an overview of the Committee’s goals and priority areas. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Drug shortages remain a persistent threat to patient care and pharmacy operations, with 270 active shortages recorded in early 2025. In this episode of Hot Topics in Pharmacy, ASHP’s Mike Ganio hosts Erin Fox and April Giles to unpack the latest data, explore the day-to-day realities health systems are facing, and examine the complex challenges shaping the future of medication access. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast will provide members with analysis of the Administration’s actions on drug pricing to date, including proposed tariffs and two separate Executive Orders (EOs). We’ll talk through key elements of the EO on Most Favored Nation pricing, how it might intersect with the earlier, more general EO on drug pricing, and what these policy shifts could mean for members. We’ll also discuss how potential tariffs on pharmaceuticals might further complicate the drug pricing picture. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast, we’ve partnered with a data science pharmacist to explore challenges that can arise when implementing artificial intelligence (AI) in pharmacy. We’ll focus on his experience with AI governance, ethical challenges, and key considerations for the everyday pharmacist. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This episode focuses on the operational considerations for the use of in vivo and viral based gene therapies in health-system pharmacies and the appropriate stakeholders. CE for this episode expires on May 31, 2027. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this Pharmacy Leadership episode, Ashley Boedecker sits down with the Section of Ambulatory Care Practitioners Awardee Jessica Skelley to discuss what membership within the section and ASHP means to her and how it has helped her develop as a pharmacy practice leader. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, members of the ASHP Pharmacy Administration and Leadership Residents’ Collaborative dive into practical strategies for becoming a highly engaged and effective learner as a Pharmacy Administration and Leadership (PAL) resident. Whether you're navigating clinical rotations or administrative responsibilities, this podcast features current PGY1 & PGY2 HSPAL residents and experienced pharmacy leaders sharing tips on fostering curiosity, building relationships, and actively participating in diverse learning environments. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Learn from experts on treatments for patients with obesity. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, Julie Dagam sits down with Andrea Roberson to discuss the upcoming session entitled Be Prepared: Frequent Findings and Trusty Tips for Pharmacy Residency Accreditation, and with Michelle Rager to discuss the upcoming session entitled “The Need for Speed”—Efficient and Effective Residency CQI and Reporting. These sessions are part of the preceptor-focused education offered at Pharmacy Futures 2025/National Pharmacy Preceptors Conference. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This episode reviews the viral replication process, common viral vectors for in vivo gene therapy, and Food and Drug Administration-approved therapies. The episode will also highlight novel in vivo gene therapies in the development pipeline. CE for this episode expires on May 25, 2027. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. In this episode ASHP sits down with Tammy McKinney, a patient living with diabetes and her pharmacist Tina Claypool of University of Louisville Health. Tammy, who is also a nurse, shares how Tina’s expertise, dedication, and care improved her health and changed her life for the better. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, we are joined by expert Kenneth A. Richman, professor of philosophy and health care ethics at MCPHS University. Join us as we discuss real-world dilemmas, ethical decision-making frameworks, and how pharmacists can uphold integrity while navigating complex healthcare systems. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join the TPTS Board of Directors as they walk through TPTS’s first strategic plan. Hear directly from the Board as they break down the key goals tied to each pillar and share what excites them most about the road ahead. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Learn from experts on treatments for patients with obesity. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Follow ASHP Career and Leadership Advisory Group members as we discuss what we learned during our APPE rotations and internships, from applying to finding leadership within the new roles. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, Julie Dagam sits down with Tiffany Pon to discuss the upcoming session entitled “A Whole New World: Navigating Resident Selection Processes”. This session is part of the preceptor-focused education offered at Pharmacy Futures 2025/National Pharmacy Preceptors Conference. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, the team from UNC Health Medical Center discusses their award-winning submission to the ASHP Best Practices. They share how their precision oncology program allowed clinicians to integrate evidence-based personalized therapies into their practice to improve patient outcomes by reducing barriers to precision oncology. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Faculty experts highlight USP <797> and discuss opportunities to reduce medication errors, with respect to sterility, stability, and compatibility when compounding parenteral nutrition and assigning a beyond use date. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Community-based residency training programs provide unique opportunities to provide patient care, establish and expand pharmacy services, and conduct targeted research and other projects relevant to community pharmacy. This podcast features three residency directors of community-based residency programs sharing insights and perspectives on the value of community-based residency training. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, Julie Dagam sits down with Janet Cooley and Suzy Larson to discuss their upcoming session entitled “Up your game: an interactive board game addressing preceptor challenges”. This session is part of the preceptor-focused education offered at Pharmacy Futures 2025/National Pharmacy Preceptors Conference. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, the team from St. Elizabeth Physicians and the University of Cincinnati discuss their award-winning submission to the ASHP Best Practices. They share how leveraging remote certified pharmacy technicians in ambulatory care helped expand clinical pharmacy services, improve value-based care, and impact their organization’s high performance on quality measures. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

The American Foundation for Suicide Prevention (AFSP) is a voluntary health organization that gives those affected by suicide a nationwide community empowered by research, education, and advocacy to take action against this leading cause of death. With local programs and events in all 50 states, AFSP’s chapters are at the forefront of suicide prevention. This podcast will highlight the intricacies and scope of suicide, review key research findings on the risk factors and warning signs for suicide, outline recommendations for suicide prevention, and provide guidance on addressing suicidal crisis or response.

Transitions of care prioritizes coordinating, integrating, and continuing care to improve patient outcomes and reduce unnecessary readmissions. Pharmacists play a significant role in this process through each level of acuity. In this episode, we discuss key elements of transitions of care from the ICU and medicine floors to the outpatient settings, navigating medication reconciliations and varying types of health systems. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Sodium Glucose Cotransporter-2 Inhibitors (SGLT2) have demonstrated improvement in patient outcomes across several disease states including patients with type 2 diabetes, heart failure and chronic kidney disease. Despite guideline recommendations for the use of these agents in each of these disease states, utilization of SGLT2 remains relatively low. This podcast discusses some of the barriers to utilization of SGLT2 and strategies to increase uptake of this therapy among patients with diabetes, heart failure and chronic kidney disease. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.